Boston Scientific Corp (BSX)vsRxsight Inc (RXST)
BSX
Boston Scientific Corp
$69.78
+2.39%
HEALTHCARE · Cap: $101.28B
RXST
Rxsight Inc
$6.26
-2.03%
HEALTHCARE · Cap: $263.69M
Smart Verdict
WallStSmart Research — data-driven comparison
Boston Scientific Corp generates 14827% more annual revenue ($20.07B vs $134.48M). BSX leads profitability with a 14.4% profit margin vs -29.0%. BSX earns a higher WallStSmart Score of 63/100 (C+).
BSX
Buy63
out of 100
Grade: C+
RXST
Avoid34
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+1.2%
Fair Value
$70.62
Current Price
$69.78
$0.84 discount
Intrinsic value data unavailable for RXST.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Growing faster than its price suggests
15.9% revenue growth
Generating 1.0B in free cash flow
Reasonable price relative to book value
Areas to Watch
Premium valuation, high expectations priced in
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -14.0% — below average capital efficiency
Revenue declined 18.9%
Comparative Analysis Report
WallStSmart ResearchBull Case : BSX
The strongest argument for BSX centers on Market Cap, PEG Ratio, Revenue Growth. Revenue growth of 15.9% demonstrates continued momentum. PEG of 0.75 suggests the stock is reasonably priced for its growth.
Bull Case : RXST
The strongest argument for RXST centers on Price/Book.
Bear Case : BSX
The primary concerns for BSX are P/E Ratio.
Bear Case : RXST
The primary concerns for RXST are EPS Growth, Market Cap, Return on Equity.
Key Dynamics to Monitor
BSX profiles as a growth stock while RXST is a turnaround play — different risk/reward profiles.
RXST carries more volatility with a beta of 1.15 — expect wider price swings.
BSX is growing revenue faster at 15.9% — sustainability is the question.
BSX generates stronger free cash flow (1.0B), providing more financial flexibility.
Bottom Line
BSX scores higher overall (63/100 vs 34/100) and 15.9% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Boston Scientific Corp
HEALTHCARE · MEDICAL DEVICES · USA
Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
Rxsight Inc
HEALTHCARE · MEDICAL DEVICES · USA
Rxsight Inc. is a pioneering healthcare technology company specializing in advanced vision correction solutions through its innovative diagnostic and surgical techniques in refractive eye surgery. Utilizing proprietary software and precision-guided laser technology, the company significantly improves patient outcomes and overall quality of life. Rxsight's strong intellectual property portfolio and strategic partnerships further enhance its competitive positioning within the expanding ophthalmic market. With a robust commitment to innovation and excellence, Rxsight is strategically poised for significant growth and impact in the evolving landscape of eye care.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?